INT MEDICAL Reports Interim Results with 11.97% Rise in Net Profit Attributable to Shareholders

Stock News08-24

INT MEDICAL (01501) has released its interim results for the six months ended June 30, 2026, reporting a revenue of RMB 596 million, representing a year-on-year increase of 29.28%.

The company recorded a profit attributable to equity shareholders of RMB 110 million, up 11.97% compared to the same period last year, with earnings per share of RMB 0.54.

The revenue growth was primarily driven by acquisitions and mergers that filled product gaps and established a comprehensive product portfolio matrix, as well as the realization of synergies through channel reuse and supply chain integration, which boosted sales of interventional medical devices.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1127726185?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-24 21:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127726185","market":"nz","top_or_hot":-1,"title":"INT MEDICAL Reports Interim Results with 11.97% Rise in Net Profit Attributable to Shareholders","media":"Stock News","content":"<p><b>INT MEDICAL</b> (01501) has released its interim results for the six months ended June 30, 2026, reporting a revenue of RMB 596 million, representing a year-on-year increase of 29.28%.<br><br>The company recorded a profit attributable to equity shareholders of RMB 110 million, up 11.97% compared to the same period last year, with earnings per share of RMB 0.54.<br><br>The revenue growth was primarily driven by acquisitions and mergers that filled product gaps and established a comprehensive product portfolio matrix, as well as the realization of synergies through channel reuse and supply chain integration, which boosted sales of interventional medical devices.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>INT MEDICAL Reports Interim Results with 11.97% Rise in Net Profit Attributable to Shareholders</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nINT MEDICAL Reports Interim Results with 11.97% Rise in Net Profit Attributable to Shareholders\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-24 21:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>INT MEDICAL</b> (01501) has released its interim results for the six months ended June 30, 2026, reporting a revenue of RMB 596 million, representing a year-on-year increase of 29.28%.<br><br>The company recorded a profit attributable to equity shareholders of RMB 110 million, up 11.97% compared to the same period last year, with earnings per share of RMB 0.54.<br><br>The revenue growth was primarily driven by acquisitions and mergers that filled product gaps and established a comprehensive product portfolio matrix, as well as the realization of synergies through channel reuse and supply chain integration, which boosted sales of interventional medical devices.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01501","symbol_name":"瑛泰医疗","start_time":0,"source_url":"","article_id":"1127726185","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127726185","pubTimestamp":1787577421,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"INT MEDICAL (01501) has released its interim results for the six months ended June 30, 2026, reporting a revenue of RMB 596 million, representing a year-on-year increase of 29.28%.The company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01501":"瑛泰医疗","BK1222":"医疗保健用品"},"translate_title":"INT MEDICAL Reports中期业绩，股东应占净利润增长11.97%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01501":1},"content_text":"INT MEDICAL (01501) has released its interim results for the six months ended June 30, 2026, reporting a revenue of RMB 596 million, representing a year-on-year increase of 29.28%.The company recorded a profit attributable to equity shareholders of RMB 110 million, up 11.97% compared to the same period last year, with earnings per share of RMB 0.54.The revenue growth was primarily driven by acquisitions and mergers that filled product gaps and established a comprehensive product portfolio matrix, as well as the realization of synergies through channel reuse and supply chain integration, which boosted sales of interventional medical devices.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1127726185","isCrawlerRequest":true}